The Journal of Allergy and Clinical Immunology
Volume 123, Issue 1 , Pages 28-34 , January 2009

Advances in pediatric asthma in 2008: Where do we go now?

  • Stanley J. Szefler, MD

      Affiliations

    • Corresponding Author InformationReprint requests: Stanley J. Szefler, MD, National Jewish Health, 1400 Jackson Street, Room J304 Molly Blank Building, Denver, CO 80206.

Received 12 November 2008 ,Accepted 14 November 2008.

References 

  1. Szefler SJ. Advances in pediatric asthma in 2007. J Allergy Clin Immunol. 2008;121:614–619
  2. National Institutes of Health. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Expert Panel Report 3: guidelines for the diagnosis and management of asthma. August 2007. NIH publication no. 07-4051. Available at: http://www.nhlbi.nih.gov/guidelines/asthma/index.htm. Accessed November, 10, 2008.
  3. Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma—summary report 2007. J Allergy Clin Immunol. 2007;120:S94–S138
  4. McIvor RA, Chapman KR. The coming of age of asthma guidelines. Lancet. 2008;372:1021–1022
  5. Frey U, Suki B. Complexity of chronic asthma and chronic obstructive pulmonary disease: implications for risk assessment and disease progression and control. Lancet. 2008;372:1088–1099
  6. Spahn JD, Covar RA. Clinical assessment of asthma progression in children and adults. J Allergy Clin Immunol. 2008;121:548–557
  7. Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet. 2008;372:1107–1119
  8. Holt EW, Cook EF, Covar RA, Spahn JD, Fuhlbrigge AL. Identifying the components of asthma health status in children with mild to moderate asthma. J Allergy Clin Immunol. 2008;121:1175–1180
  9. Bender B, Zhang L. Negative affect, medication adherence, and asthma control in children. J Allergy Clin Immunol. 2008;122:490–495
  10. Pelkonen A, Kari O, Selroos O, Nikander K, Haahtela T, Turpeinen M. Ophthalmologic findings in children with asthma receiving inhaled budesonide. J Allergy Clin Immunol. 2008;122:832–834
  11. Holbrook JT, Harik-Khan R. Montelukast and emotional well-being as a marker for depression: results from three randomized double-masked clinical trials. J Allergy Clin Immunol. 2008;122:828–829
  12. Busse WW, Pedersen S, Pauwels RA, Tan WC, Chen YZ, Lamm CJ, et al. START Investigators Group. The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma. J Allergy Clin Immunol. 2008;121:1167–1174
  13. Zeiger RS, Hay JW, Contreras R, Chen W, Quinn VP, Seal B, et al. Asthma costs and utilization in a managed care organization. J Allergy Clin Immunol. 2008;121:885–892
  14. Stingone JA, Claudio L. Disparities in allergy testing and health outcomes among urban children with asthma. J Allergy Clin Immunol. 2008;122:748–753
  15. Canino G, Vila D, Normand ST, Acosta-Pérez E, Ramírez R, García P, et al. Reducing asthma health disparities in poor Puerto Rican children: the effectiveness of a culturally tailored family intervention. J Allergy Clin Immunol. 2008;121:665–670
  16. Reed CE. What the 21st century does not know about asthma—yet. J Allergy Clin Immunol. 2008;121:601–602
  17. Pistiner M, Gold DR, Abdulkerim H, Hoffman E, Celedón JC. Birth by cesarean section, allergic rhinitis, and allergic sensitization among children with a parental history of atopy. J Allergy Clin Immunol. 2008;122:274–279
  18. Kumar R, Yu Y, Story RE, Pongracic JA, Gupta R, Pearson C, et al. Prematurity, chorioamnionitis, and the development of recurrent wheezing: A prospective birth cohort study. J Allergy Clin Immunol. 2008;121:878–884
  19. McDonald KL, Huq SI, Lix LM, Becker AB, Kozyrskyj AL. Delay in diphtheria, pertussis, tetanus vaccination is associated with a reduced risk of childhood asthma. J Allergy Clin Immunol. 2008;121:626–631
  20. Kim JS, Ouyang F, Pongracic JA, Fang Y, Wang B, Liu X, et al. Dissociation between the prevalence of atopy and allergic disease in rural China among children and adults. J Allergy Clin Immunol. 2008;122:929–935
  21. Donohue KM, Al-alem U, Perzanowski MS, Chew GL, Johnson A, Divjan A, et al. Anti-cockroach, mouse IgE is associated with early wheeze and atopy in an inner-city birth cohort. J Allergy Clin Immunol. 2008;122:914–920
  22. Foster SB, McIntosh K, Thompson B, Lu M, Yin W, Rich KC, et al. Increased incidence of asthma in HIV-infected children treated with highly active antiretroviral therapy in the National Institutes of Health Women and Infants Transmission Study. J Allergy Clin Immunol. 2008;122:159–165
  23. Burgess JA, Dharmage SC, Byrnes GB, Matheson MC, Gurrin LC, Wharton CL, et al. Childhood eczema and asthma incidence and persistence: a cohort study from childhood to middle age. J Allergy Clin Immunol. 2008;122:280–285
  24. Shaaban R, Zureik M, Soussan D, Neukirch C, Heinrich J, Sunyer J, et al. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet. 2008;372:1049–1057
  25. Lowe AJ, Carlin JB, Bennett CM, Hosking CS, Abramson MJ, Hill DJ, et al. Do boys do the atopic march while girls dawdle?. J Allergy Clin Immunol. 2008;121:1190–1195
  26. Beasley R, Clayton T, Crane J, von Mutius E, Lai CKW, Montefort S, et al. ISAAC Phase Three Study Group Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6-7 years: Analysis from Phase Three of the ISAAC programme. Lancet. 2008;372:1039–1048
  27. Tepper RS, Llapur CJ, Jones MH, Tiller C, Coates C, Kimmel R, et al. Expired nitric oxide and airway reactivity in infants at risk for asthma. J Allergy Clin Immunol. 2008;122:760–765
  28. Elliott L, Henderson J, Northstone K, Chiu GY, Dunson D, London SJ. Prospective study of breast-feeding in relation to wheeze, atopy, and bronchial responsiveness in the Avon Longitudinal Study of Parents and Children (ASPAC). J Allergy Clin Immunol. 2008;122:49–54
  29. Sicherer SH, Burks AW. Maternal and infant diets for prevention of allergic diseases: understanding menu changes in 2008. J Allergy Clin Immunol. 2008;122:29–33
  30. Stern DA, Morgan WJ, Halonen M, Wright AL, Martinez FD. Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study. Lancet. 2008;372:1058–1064
  31. Sly PD, Boner AL, Bjorksten B, Bush A, Custovic A, Eigenmann PA, et al. Early identification of atopy in the prediction of persistent asthma in children. Lancet. 2008;372:1100–1106
  32. Nicolaou NC, Simpson A, Lowe LA, Murray CS, Woodcock A, Custovic A. Day-care attendance, position in sibship, and early childhood wheezing: a population-based birth cohort study. J Allergy Clin Immunol. 2008;122:500–506
  33. Guilbert TW, Morgan WJ, Zeiger RS, Mauger DT, Boehmer SJ, Szefler SJ, et al. Two year inhaled corticosteroid treatment on subsequent asthma in high-risk toddlers. N Engl J Med. 2006;354:1985–1997
  34. Litonjua AA, Gold DR. Asthma and obesity: common early-life influences in the inception of disease. J Allergy Clin Immunol. 2008;121:1075–1084
  35. Shore SA. Obesity and asthma: possible mechanisms. J Allergy Clin Immunol. 2008;121:1087–1093
  36. Mehra R, Redline S. Sleep apnea: a proinflammatory disorder that coaggregates with obesity. J Allergy Clin Immunol. 2008;121:1096–1102
  37. Mosen DM, Schatz M, Magid DJ, Camargo CA. The relationship between obesity and asthma severity and control in adults. J Allergy Clin Immunol. 2008;122:507–511
  38. Taveras EM, Rifas-Shiman SL, Camargo CA, Gold DR, Litonjua AA, Oken E, et al. Higher adiposity in infancy associated with recurrent wheeze in a prospective cohort of children. J Allergy Clin Immunol. 2008;121:1161–1166
  39. Szefler SJ. Asthma exacerbations: putting a lid on the volcano. J Allergy Clin Immunol. 2008;122:697–699
  40. Sears MR. Epidemiology of asthma exacerbations. J Allergy Clin Immunol. 2008;122:662–668
  41. Sykes A, Johnston SL. Etiology of asthma exacerbations. J Allergy Clin Immunol. 2008;122:685–688
  42. Kelly JT, Busse WW. Host immune responses to rhinovirus: mechanisms in asthma. J Allergy Clin Immunol. 2008;122:671–682
  43. Covar RA, Szefler SJ, Zeiger RS, Sorkness CA, Moss M, Mauger DT, et al. Childhood Asthma Research and Education Network Factors associated with asthma exacerbations during a long-term clinical trial of controller medications in children. J Allergy Clin Immunol. 2008;122:741–747
  44. Sorkness CA, Lemanske RF, Mauger DT, Boehmer SJ, Chinchilli VM, Martinez FD, et al. Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. J Allergy Clin Immunol. 2007;119:64–72
  45. Sorkness RL, Gonzalez-Fernandez G, Billmeyer EE, Evans MD, Gern JE, Jarjour NN. The asthma index: a continuous variable to characterize exacerbations of asthma. J Allergy Clin Immunol. 2008;122:838–840
  46. Fitch KD, Sue-Chu M, Anderson SD, Boulet LP, Hancox RJ, McKenzie DC, et al. Asthma and the elite athlete: summary of the International Olympic Committee's Consensus Conference, Lausanne, Switzerland, January 22-24, 2008. J Allergy Clin Immunol. 2008;122:254–260
  47. Anderson SD, Kippelen P. Airway injury as a mechanism for exercise-induced bronchoconstriction in elite athletes. J Allergy Clin Immunol. 2008;122:225–235
  48. Pedersen L, Lund TK, Barnes PJ, Kharitonov SA, Backer V. Airway responsiveness and inflammation in adolescent elite swimmers. J Allergy Clin Immunol. 2008;122:322–327
  49. Rundell KW, Slee JB. Exercise and other indirect challenges to demonstrate asthma or exercise-induced bronchoconstriction in athletes. J Allergy Clin Immunol. 2008;122:238–246
  50. Weinberger M. Long-acting β-agonists and exercise. J Allergy Clin Immunol. 2008;122:251–253
  51. Sharma S, Litonjua AA, Tantisira KG, Fuhlbrigge AL, Szefler SJ, Strunk RC, et al. CAMP Research Group Clinical predictors and outcomes of consistent bronchodilator response in the Childhood Asthma Management Program. J Allergy Clin Immunol. 2008;122:921–928
  52. Goleva E, Hauk PJ, Hall CF, Liu AH, Riches DWH, Martin RJ, et al. Corticosteroid-resistant asthma is associated with classic antimicrobial activation of airway macrophages. J Allergy Clin Immunol. 2008;122:550–559
  53. Szefler SJ. Asthma progression: can we and should we measure it?. J Allergy Clin Immunol. 2008;121:598–600
  54. Panettieri RA, Covar RA, Grant E, Hillyer EV, Bacharier L. Natural history of asthma: persistence versus progression—does the beginning predict the end?. J Allergy Clin Immunol. 2008;121:607–613
  55. Broide DH. Immunologic and inflammatory mechanisms that drive asthma progression to remodeling. J Allergy Clin Immunol. 2008;121:560–570
  56. Holloway JW, Yang IA, Holgate ST. Interpatient variability in rates of asthma progression: can genetics provide an answer?. J Allergy Clin Immunol. 2008;121:573–579
  57. Leigh R, Oyelusi W, Wiehler S, Koetzler R, Zaheer RS, Newton R, et al. Human rhinovirus infection enhances airway epithelial cell production of growth factors involved in airway remodeling. J Allergy Clin Immunol. 2008;121:1238–1245
  58. Sackesen C, Ercan H, Dizdar E, Soyer O, Gumus P, Nursal Tosun B, et al. A comprehensive evaluation of the enzymatic and nonenzymatic antioxidant systems in childhood asthma. J Allergy Clin Immunol. 2008;122:78–85
  59. Fitzpatrick AM, Holguin F, Teague WG, Brown LAS. Alveolar macrophage phagocytosis is impaired in children with poorly controlled asthma. J Allergy Clin Immunol. 2008;121:1372–1378
  60. Bush RK, Peden D. Advances in environmental and occupational respiratory disease in 2007. J Allergy Clin Immunol. 2008;121:1359–1362
  61. Gupta RS, Zhang X, Sharp LK, Shannon JJ, Weiss KB. Geographic variability in childhood asthma prevalence in Chicago. J Allergy Clin Immunol. 2008;121:639–645
  62. O'Connor GT, Neas L, Vaughn B, Kattan M, Mitchell H, Crain EF, et al. Acute respiratory health effects of air pollution on children with asthma in US inner cities. J Allergy Clin Immunol. 2008;121:1133–1139
  63. Tovey ER, Almqvist C, Li Q, Crisafulli D, Marks GB. Nonlinear relationship of mite allergen exposure to mite sensitization and asthma in a birth cohort. J Allergy Clin Immunol. 2008;122:114–118
  64. Kumar R, Curtis LM, Khiani S, Moy J, Shalowitz MU, Sharp L, et al. A community-based study of tobacco smoke exposure among inner city children with asthma in Chicago. J Allergy Clin Immunol. 2008;122:754–759
  65. Rabinovitch N, Strand M, Stuhlman K, Gelfand EG. Exposure to tobacco smoke increases leukotriene E4–related albuterol usage and response to montelukast. J Allergy Clin Immunol. 2008;121:1365–1371
  66. Rayens MK, Burkhart PV, Zhang M, Lee S, Moser DK, Mannino D, et al. Reduction in asthma-related emergency department visits after implementation of a smoke-free law. J Allergy Clin Immunol. 2008;122:537–541
  67. Ginde AA, Espinola JA, Camargo CA. Improved overall trends but persistent racial disparities in emergency department visits for acute asthma, 1993-2005. J Allergy Clin Immunol. 2008;122:313–318
  68. Strunk RC, Bacharier LB, Phillips BR, Szefler SJ, Zeiger RS, Chinchilli VM, et al. Childhood Asthma Research and Education Network of the National Heart, Lung and Blood Institute Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate to severe childhood asthma study. J Allergy Clin Immunol. 2008;122:1138–1144
  69. Bacharier LB, Phillips BR, Zeiger RS, Szefler SJ, Martinez FD, Lemanske RF, et al. Childhood Asthma Research and Education Network of the National Heart, Lung and Blood Institute Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing. J Allergy Clin Immunol. 2008;122:1127–1135
  70. Moeller A, Diefenbacher C, Lehmann A, Rochat M, Brooks-Wildhaber J, Hall GL, et al. Exhaled nitric oxide distinguishes between subgroups of preschool children with respiratory symptoms. J Allergy Clin Immunol. 2008;121:705–709
  71. Szefler SJ, Mitchell H, Sorkness CA, Gergen PJ, O'Connor GT, Morgan WJ, et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomized controlled trial. Lancet. 2008;372:1065–1072
  72. Ono E, Mita H, Taniguchi M, Higashi N, Tsuburai T, Hasegawa M, et al. Increase in inflammatory mediator concentrations in exhaled breath condensate after allergen inhalation. J Allergy Clin Immunol. 2008;122:768–773
  73. Romieu I, Barraza-Villarreal A, Escamilla-Nuñez C, Almstrand AC, Diaz-Sanchez D, Sly PD, et al. Exhaled breath malondialdehyde as a marker of effect of exposure to air pollution in children with asthma. J Allergy Clin Immunol. 2008;121:903–909
  74. Steinke JW, Rich SS, Borish L. Genetics of allergic disease. J Allergy Clin Immunol. 2008;121:S384–S387
  75. Vercelli D. Advances in asthma and allergy genetics in 2007. J Allergy Clin Immunol. 2008;122:267–271
  76. Chatterjee R, Batra J, Das S, Kumar Sharma S, Ghosh B. Genetic association of acidic mammalian chitinase with atopic asthma and serum total IgE levels. J Allergy Clin Immunol. 2008;122:202–208
  77. Tavendale R, Macgregor DF, Mukhopadhyay S, Palmer CNA. A polymorphism controlling ORMDL3 expression is associated with asthma that is poorly controlled by current medications. J Allergy Clin Immunol. 2008;121:860–863
  78. Ueda T, Niimi A, Matsumoto H, Takemura M, Yamaguchi M, Matsuoka H, et al. TGFB1 promoter polymorphism C-509T and pathophysiology of asthma. J Allergy Clin Immunol. 2008;121:659–664
  79. Kormann MSD, Depner M, Hartl D, Klopp N, Illig T, Adamski J, et al. Toll-like receptor heterodimer variants protect from childhood asthma. J Allergy Clin Immunol. 2008;122:86–92
  80. Hunninghake GM, Soto-Quirós ME, Lasky-Su J, Avila L, Ly NP, Liang C, et al. Dust mite exposure modifies the effect of functional IL10 polymorphisms on allergy and asthma exacerbations. J Allergy Clin Immunol. 2008;122:93–98
  81. Weidinger S, O'Sullivan M, Illig T, Baurecht H, Depner M, Rodriguez E, et al. Filaggrin mutations, atopic eczema, hay fever, and asthma in children. J Allergy Clin Immunol. 2008;121:1203–1209
  82. Bouzigon E, Corda E, Aschard H, Dizier M-H, Boland A, Bousquet J, et al. Effect of 17q21 variants and smoking exposure in early-onset asthma. N Engl J Med. 2008;359:1985–1994
  83. Adcock IM, Caramori G, Chung KF. New targets for drug development in asthma. Lancet. 2008;372:1073–1087
  84. Casale TB, Stokes JR. Immunomodulators for allergic respiratory disorders. J Allergy Clin Immunol. 2008;121:288–296
  85. Cousins DJ, McDonald J, Lee TH. Therapeutic approaches for control of transcription factors in allergic disease. J Allergy Clin Immunol. 2008;121:803–809
  86. Bhavsar P, Ahmad T, Adcock IM. The role of histone deacetylases in asthma and allergic diseases. J Allergy Clin Immunol. 2008;121:580–584
  87. Chatila TA, Li N, Garcia-Lloret M, Kim HJ, Nel AE. T-cell effector pathways in allergic diseases: transcriptional mechanisms and therapeutic targets. J Allergy Clin Immunol. 2008;121:812–823

 Supported in part by Public Health Services Research Grants HR-16048, HL64288, HL51834, AI-25496, HL081335, and HL075416; General Clinical Research Center Grant 5 MO1 RR00051; and the Colorado Cancer, Cardiovascular and Pulmonary Disease Program.

 Disclosure of potential conflict of interest: S. J. Szefler has served as a consultant for GlaxoSmithKline, Genentech, and Merck and has received research support from the National Institutes of Health, the National Heart, Lung, and Blood Institute, the National Institute of Allergy and Infectious Diseases, Ross Pharmaceuticals, and GlaxoSmithKline.

PII: S0091-6749(08)02185-4

doi: 10.1016/j.jaci.2008.11.002

The Journal of Allergy and Clinical Immunology
Volume 123, Issue 1 , Pages 28-34 , January 2009

Article Tools